Form 8-K - Current report:
SEC Accession No. 0001641172-25-013942
Filing Date
2025-06-06
Accepted
2025-06-06 09:29:09
Documents
14
Period of Report
2025-06-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 30495
2 EX-99.1 ex99-1.htm EX-99.1 20483
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6897
  Complete submission text file 0001641172-25-013942.txt   230986

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bmra-20250604.xsd EX-101.SCH 3017
5 XBRL LABEL FILE bmra-20250604_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE bmra-20250604_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3547
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-37863 | Film No.: 251029064
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)